<DOC>
	<DOCNO>NCT00049335</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness capecitabine treat old patient metastatic recurrent colorectal cancer surgically remove .</brief_summary>
	<brief_title>S0030 : Capecitabine Treating Older Patients W/Metastatic Recurrent Colorectal Cancer That Can Be Surgically Removed</brief_title>
	<detailed_description>OBJECTIVES : - Determine feasibility enrol patient age 70 unresectable metastatic recurrent colorectal cancer structure phase II study . - Determine anticancer efficacy capecitabine , term objective response rate ( confirm unconfirmed , complete partial response ) 2-year survival , patient . - Determine toxicity tolerability drug patient . - Determine feasibility use standardized self-report measure comorbidity , depression , functional status patient treat drug . - Determine clinical pharmacology drug patient . - Determine whether patient 60 year age treat drug clinical pharmacologic parameter similar report literature . OUTLINE : This multicenter study . Patients stratify accord age ( 70 vs 18 59 ) . Patients receive oral capecitabine twice daily day 1-14 . Treatment repeat every 21 day 18 course absence disease progression unacceptable toxicity . Patients follow every 6 month 3 year . PROJECTED ACCRUAL : A total 80 patient ( 60 patient age 70 , 20 patient age 18 59 ) accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm metastatic recurrent colorectal cancer amenable surgical resection Measurable disease No known brain metastasis MRI CT scan PATIENT CHARACTERISTICS : Age 70 OR 18 59 Performance status Zubrod 02 Life expectancy Not specify Hematopoietic Absolute granulocyte count least 1,000/mm^3 Platelet count least 100,000/mm^3 Hepatic Bilirubin great 2 time upper limit normal ( ULN ) SGOT ( serum glutamate oxaloacetate transaminase ) SGPT ( serum glutamate pyruvate transaminase ) great 2 time ULN Renal Creatinine great 2 time ULN Creatinine clearance great 50 mL/min Other Not pregnant nursing Fertile patient must use effective contraception HIV negative No known seizure disorder No malignancy except adequately treat basal cell squamous cell skin cancer , carcinoma situ cervix , adequately treated stage I II cancer currently complete remission , cancer patient disease free 5 year PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No prior chemotherapy advanced cancer Prior adjuvant chemotherapy allow provide recurrence occur 1 year last treatment Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify Other At least 4 week since prior sorivudine brivudine No concurrent sorivudine brivudine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>recurrent colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
</DOC>